Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
SVA:NASDAQ
Sinovac Biotech Ltd
$6.47
0.00%
(0.00) 1D
Feb 22, 5:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
Shares outstanding
59.32M
No. of employees
3K
News stories
From sources across the web
Profile
Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government. Wikipedia
About Sinovac Biotech Ltd
CEOWeidong Yin
Employees3.04K
Founded2001
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2016
Dec 2016
Mar 2024
Jun 2024
Revenue
-
-
60.67M
60.67M
Cost of goods sold
-
-
20.42M
20.42M
Cost of revenue
-
-
20.42M
20.42M
Research and development expenses
-
-
72.03M
72.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
103.17M
103.17M
Operating expense
-
-
174.35M
174.35M
Total operating expenses
-
-
194.76M
194.76M
Operating income
-
-
-134.09M
-134.09M
Other non operating income
-
-
83.24M
83.24M
EBT including unusual items
-
-
-32.60M
-32.60M
EBT excluding unusual items
-
-
-29.91M
-29.91M
Income tax expense
-
-
1.72M
1.72M
Effective tax rate
-
-
-5.26%
-5.26%
Other operating expenses
-
-
-522.00K
-522.00K
Net income
-
-
-3.95M
-3.95M
Net profit margin
-
-
-6.51%
-6.51%
Earnings per share
-
-
-
-
Interest and investment income
-
-
22.03M
22.03M
Interest expense
-
-
-1.09M
-1.09M
Net interest expenses
-
-
20.94M
20.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-99.97M
-99.97M
Gain or loss from assets sale
-
-
2.69M
2.69M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more